By Chelsea Naso ( October 31, 2017, 11:41 AM EDT) -- Japan's Kirin Holdings Co. Ltd. said Tuesday it will exit its pharmaceuticals research and development joint venture with California-based Amgen Inc. in a $780 million deal, noting that the U.S. venture has "almost fully completed its expected role" after roughly three decades....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.